Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis
- PMID: 39937013
- PMCID: PMC11817138
- DOI: 10.3390/cells14030222
Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis
Abstract
Idiopathic Pulmonary Fibrosis (IPF) is an epithelial-driven interstitial lung disease of unknown etiology characterized by the excessive proliferation of fibroblast populations that synthesize large amounts of extracellular matrix. In this devastating disorder, all aging hallmarks appear prematurely or are altered. This review highlights key findings about IPF characteristics recently recognized as hallmarks of aging, including mechanical alterations, inflammaging, dysbiosis, alternative splicing, and disabled macroautophagy. It also revisits the classic hallmarks of aging, which encompass stem cell exhaustion, cellular senescence, and altered intercellular communication. Enhancing our understanding of the fundamental processes that underlie the altered hallmarks of aging in IPF may facilitate the development of innovative experimental strategies to improve therapeutic outcomes.
Keywords: aging hallmarks; alternative splicing; dysbiosis; idiopathic pulmonary fibrosis; inflammaging; mechanical alterations.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Mechanistic links between aging and lung fibrosis.Biogerontology. 2013 Dec;14(6):609-15. doi: 10.1007/s10522-013-9451-6. Epub 2013 Aug 9. Biogerontology. 2013. PMID: 23929205 Free PMC article. Review.
-
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.Ann Am Thorac Soc. 2016 Dec;13 Suppl 5:S417-S421. doi: 10.1513/AnnalsATS.201605-341AW. Ann Am Thorac Soc. 2016. PMID: 28005427 Review.
-
The Aging Lung and Idiopathic Pulmonary Fibrosis.Am J Med Sci. 2019 May;357(5):384-389. doi: 10.1016/j.amjms.2019.02.008. Epub 2019 Feb 12. Am J Med Sci. 2019. PMID: 31010465 Review.
-
Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.Semin Cell Dev Biol. 2020 May;101:104-110. doi: 10.1016/j.semcdb.2019.12.008. Epub 2019 Dec 24. Semin Cell Dev Biol. 2020. PMID: 31879264 Free PMC article. Review.
-
Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.Stem Cell Res Ther. 2018 Sep 26;9(1):257. doi: 10.1186/s13287-018-0970-6. Stem Cell Res Ther. 2018. PMID: 30257725 Free PMC article.
Cited by
-
Inflammaging-Driven Osteoporosis: Is a Galectin-Targeted Approach Needed?Int J Mol Sci. 2025 Jul 4;26(13):6473. doi: 10.3390/ijms26136473. Int J Mol Sci. 2025. PMID: 40650248 Free PMC article. Review.
-
Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis.Eur J Med Res. 2025 Jul 2;30(1):542. doi: 10.1186/s40001-025-02755-5. Eur J Med Res. 2025. PMID: 40605040 Free PMC article. Review.
References
-
- Selman M., King T.E., Jr., Pardo A., American Thoracic Society. European Respiratory Society. American College of Chest Physicians Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001;134:136–151. doi: 10.7326/0003-4819-134-2-200101160-00015. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical